Activity of Oritavancin (LY333328), an Investigational Glycopeptide, Compared to That of Vancomycin against Multidrug-Resistant Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model

類似資料

• Influence of Human Serum on Pharmacodynamic Properties of an Investigational Glycopeptide, LY333328, and Comparator Agents against Staphylococcus aureus
  著者:: Zhanel, George G., 等
  出版事項: (1998)
• Cellular Pharmacokinetics and Pharmacodynamics of the Glycopeptide Antibiotic Oritavancin (LY333328) in a Model of J774 Mouse Macrophages
  著者:: Van Bambeke, Françoise, 等
  出版事項: (2004)
• Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.
  著者:: Mercier, R C, 等
  出版事項: (1997)
• Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model
  著者:: Zelenitsky, S. A., 等
  出版事項: (1999)
• In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.
  著者:: Schwalbe, R S, 等
  出版事項: (1996)